Tag Archives: CD30

29Mar/21

Comprehensively Review Targets for ADC

March 29, 2021ReviewADC targets, CD19, CD30, CD37, Trop2bioadc

At present, ADC drugs are mainly used in the field of tumors, so antigenic targets are required to be highly expressed in tumor cells but with low or no expression in normalRead More…

30Nov/20

Analysis of the ADCs Drugs Approved by FDA

November 30, 2020ReviewADC, CD30, FDA ADCsbioadc

Antibody-drug conjugate (ADC) has achieved great progress in the past decade. So far, ten ADC drugs have been approved by the FDA, of which five were approved in 2019 and 2020, andRead More…

Home
Antibody-drug Conjugates Research
Antibody-drug Conjugates Manufacturing
News